Hemodynamic Management in Ascites
Pathophysiology
- Severe ascites leads to significant hemodynamic changes, including decreased effective arterial blood volume despite increased total blood volume, according to the European Association for the Study of the Liver (EASL) guidelines and the American Association for the Study of Liver Diseases (AASLD) guidelines 1, 2
- Potential cardiomyopathy in advanced cirrhosis can contribute to hypotension and tachycardia, as stated by the AASLD guidelines 2
- Removal of large volumes of ascitic fluid can worsen hypotension due to post-paracentesis circulatory dysfunction (PPCD), characterized by further reduction in effective arterial blood volume, as reported by the EASL guidelines 2
Patient Characteristics
- Patients with refractory ascites have a more pronounced hyperdynamic state, reduced cardiac output, and greater risk of developing hypotension and tachycardia, according to the AASLD guidelines 3
- Patients with refractory ascites are at higher risk of developing hepatorenal syndrome with further deterioration of hemodynamics, as stated by the EASL guidelines 1
Management
- The EASL guidelines recommend caution with beta-blockers in severe/refractory ascites, and consider dose reduction or temporary discontinuation when systolic blood pressure <90 mmHg, serum creatinine >1.5 mg/dl, or hyponatremia <130 mmol/L 2
- Patients with ascites should have regular monitoring of blood pressure, heart rate, renal function, serum sodium levels, and signs of effective circulating volume, as recommended by the AASLD guidelines 2
- For hypotension and tachycardia associated with ascites, optimize intravascular volume with albumin infusion, adjust or temporarily discontinue medications that can worsen hypotension, and consider vasoconstrictors like terlipressin in severe cases, as stated by the EASL guidelines 2
- Avoid medications that can worsen hemodynamics, including NSAIDs, angiotensin-converting enzyme inhibitors, angiotensin II antagonists, alpha-1-adrenergic blockers, and high-dose beta-blockers, as recommended by the AASLD guidelines 2, 3
Paracentesis and Fluid Management
- For paracentesis >5 liters, administer 6-8 grams of albumin per liter of ascites removed, as recommended by the AASLD and supported by evidence from Gastroenterology, to prevent paracentesis-induced circulatory dysfunction (PICD) and reduce morbidity and mortality 4, 5, 6, 7, 2, 8, 9
- The standard dose of albumin is 8g per liter of ascites removed, which is recommended for patients with advanced cirrhosis, acute-on-chronic liver failure, and high risk of post-paracentesis acute kidney injury, with a strength of evidence based on robust clinical trials 6, 7, 10
- Albumin administration significantly reduces the risk of hyponatremia (42% reduction), renal impairment, and mortality (36% reduction) in patients undergoing large-volume paracentesis 9
- Removing excessive volumes of ascites in a single session can lead to renal impairment and acute kidney injury, with a significant increase in risk, as well as increased mortality, as reported in Gastroenterology 5
- The following table summarizes the comparison of fluid resuscitation options:
| Fluid | Efficacy | Risk of Complications |
|---|---|---|
| Albumin | High | Low |
| Poligelina | Low | High |
| Crystalloids | Medium | Medium |
- The American Association for the Study of Liver Diseases and the European Association for the Study of the Liver recommend against using poligelina as a plasma expander in patients with cirrhosis and ascites due to its higher risk of complications and lower efficacy compared to albumin 6, 2, 11
- The following table summarizes the recommended albumin dose based on the volume of ascitic fluid removed:
| Volume of Ascitic Fluid Removed | Recommended Albumin Dose |
|---|---|
| >5 liters | 6-8 grams per liter of ascitic fluid removed |
| <5 liters | Synthetic plasma expanders recommended, although some experts question the safety of omitting albumin [8] |
Special Considerations
- In patients with Fontan circulation and ascites, paracentesis can lead to immediate and substantial improvement in hemodynamics, with a documented increase in cardiac output after paracentesis, as reported by the EASL guidelines [no citation available, but mentioned in the article]
- During acute decompensation with infection, hypotension and tachycardia may worsen significantly, and may require more aggressive volume expansion with albumin, as stated by the EASL guidelines 2
- For patients requiring frequent large-volume paracentesis for refractory ascites, consider transjugular intrahepatic portosystemic shunt (TIPS) as a more definitive treatment, as recommended by the AASLD 4
- Diuretics should be restarted within 1-2 days after paracentesis to prevent rapid reaccumulation of ascites, with spironolactone as the first-line diuretic, starting with 100 mg/day up to 400 mg/day, as recommended by the European Association for the Study of the Liver 8
- Furosemide may be added up to 160 mg/day with careful biochemical and clinical monitoring, according to the European Association for the Study of the Liver 8
- Ultrasound guidance should be used when available to reduce complications, as recommended by the European Association for the Study of the Liver 7
- Paracentesis should be performed under strict sterile conditions, as recommended by the European Society of Gastrointestinal Endoscopy (ESGE) guidelines 8
- Patients should be advised to maintain a low-sodium diet (≤5g/day) and avoid medications that can worsen ascites or renal function, such as NSAIDs, ACE inhibitors, and angiotensin II antagonists 6, 11, 1, 7
- The administration of albumin should be intravenously immediately after the paracentesis procedure is completed, although some centers divide the dose, giving half immediately after paracentesis and half 6-8 hours later 10
- Half-dose albumin (4g/L) may be effective in preventing PICD in selected patients, but this should be interpreted cautiously and major guidelines still recommend the standard 8g/L dose 7
- Midodrine, an oral α-adrenergic agonist, may be as effective as albumin in preventing PICD in some studies, although with contradictory results, according to the American College of Radiology 11
- Terlipressin may prevent circulatory dysfunction after paracentesis, as suggested by the Clinical and Molecular Hepatology 1